Literature DB >> 9476923

Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer.

L Kostakoglu1, P Kiratli, S Ruacan, M Hayran, S Emri, E L Ergün, C F Bekdik.   

Abstract

UNLABELLED: In a prospective study, we correlated the washout rates of 99mTc-sestamibi (MIBI) and the degree of MIBI accumulation with the expression of P-glycoprotein (Pgp) in tumor tissues in a total of 46 patients with lung cancer.
METHODS: All patients underwent early (30 min) and delayed (3 hr) MIBI imaging and bronchoscopic biopsy before initiation of chemo- or radiotherapy. The interval between biopsy and imaging varied between 2 and 10 days. All patients had radiologically detectable tumors. Immunohistochemical studies were performed on paraffin sections using a monoclonal antibody, JSB-1, developed against the internal epitope of Pgp. Normal tissue and tumor washout rates and tumor-to-background ratios were correlated with the level of Pgp expression.
RESULTS: There was an inverse correlation between tumor-to-background ratios and the density of Pgp (p = 0.001), whereas there was no appreciable correlation between tumor washout rates of MIBI and the level of Pgp expression (p = 0.414).
CONCLUSION: The current data strongly suggest that, although the reduced ability for the tumors to accumulate MIBI correlates well with the increased levels of Pgp expression, tumor washout rates of MIBI do not correlate with the density of Pgp in tumor tissues. Our results also warrant additional research for correlating immunohistological and imaging findings with messenger RNA levels determined by polymerase chain reaction and flow cytometry.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476923

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer.

Authors:  Masato Kobayashi; Takafumi Tsujiuchi; Yuya Okui; Asuka Mizutani; Kodai Nishi; Takeo Nakanishi; Ryuichi Nishii; Kazuki Fukuchi; Ikumi Tamai; Keiichi Kawai
Journal:  Pharm Res       Date:  2018-11-29       Impact factor: 4.200

2.  Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.

Authors:  Sheng-Pin Changlai; Chang-Shu Tsai; Hueisch-Jy Ding; Wen-Tao Huang; Albert Kao; Wu-Huei Hsu
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.

Authors:  Teréz Márián; Gábor Szabó; Katalin Goda; Henrietta Nagy; Nóra Szincsák; István Juhász; László Galuska; László Balkay; Pál Mikecz; Lajos Trón; Zoltán Krasznai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-27       Impact factor: 9.236

4.  Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

Authors:  Hai Wang; Xiao-Ping Chen; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancer.

Authors:  Tzu-I J Yang; Tjeerd S Aukema; Harm van Tinteren; Sjaak Burgers; Renato Valdés Olmos; Marcel Verheij
Journal:  Mol Imaging Biol       Date:  2009-09-12       Impact factor: 3.488

6.  Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.

Authors:  C-M Shih; Y-C Shiau; J-J Wang; S-T Ho; A Kao
Journal:  Lung       Date:  2003       Impact factor: 2.584

7.  Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.

Authors:  Célia M F Gomes; Mick Welling; Ivo Que; Niek V Henriquez; Gabri van der Pluijm; Salvatore Romeo; Antero J Abrunhosa; M Filomena Botelho; Pancras C W Hogendoorn; Ernest K J Pauwels; Anne Marie Cleton-Jansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-01       Impact factor: 9.236

Review 8.  Evaluation of Cardiac Mitochondrial Function by a Nuclear Imaging Technique using Technetium-99m-MIBI Uptake Kinetics.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013

Review 9.  Window of opportunity clinical trial designs to study cancer metabolism.

Authors:  Francesca Aroldi; Simon R Lord
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

10.  Imaging of hepatic drug transporters with [131I]6-β-iodomethyl-19-norcholesterol.

Authors:  Masato Kobayashi; Kodai Nishi; Asuka Mizutani; Tsuzumi Hokama; Miki Matsue; Tetsuya Tsujikawa; Takeo Nakanishi; Ryuichi Nishii; Ikumi Tamai; Keiichi Kawai
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.